Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$2.66 - $4.33 $1,231 - $2,004
463 New
463 $1,000
Q4 2022

Feb 08, 2023

SELL
$2.11 - $3.25 $10,248 - $15,785
-4,857 Reduced 90.6%
504 $1,000
Q3 2022

Nov 10, 2022

BUY
$1.32 - $3.14 $7,076 - $16,833
5,361 New
5,361 $14,000
Q2 2022

Aug 10, 2022

SELL
$0.78 - $1.9 $1,935 - $4,713
-2,481 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$1.83 - $4.48 $3,680 - $9,009
-2,011 Reduced 44.77%
2,481 $5,000
Q4 2021

Feb 14, 2022

SELL
$2.35 - $5.58 $1,229 - $2,918
-523 Reduced 10.43%
4,492 $21,000
Q3 2021

Nov 15, 2021

BUY
$2.25 - $3.03 $8,482 - $11,423
3,770 Added 302.81%
5,015 $13,000
Q2 2021

Aug 13, 2021

SELL
$2.72 - $4.04 $14,372 - $21,347
-5,284 Reduced 80.93%
1,245 $4,000
Q1 2021

May 12, 2021

BUY
$3.62 - $6.34 $16,590 - $29,056
4,583 Added 235.51%
6,529 $25,000
Q4 2020

Feb 11, 2021

BUY
$3.82 - $5.32 $294 - $409
77 Added 4.12%
1,946 $10,000
Q3 2020

Nov 12, 2020

BUY
$3.7 - $5.47 $1,835 - $2,713
496 Added 36.13%
1,869 $8,000
Q2 2020

Jul 31, 2020

SELL
$4.59 - $8.96 $4,645 - $9,067
-1,012 Reduced 42.43%
1,373 $6,000
Q1 2020

May 01, 2020

BUY
$2.65 - $6.08 $6,320 - $14,500
2,385 New
2,385 $9,000
Q4 2019

Feb 14, 2020

SELL
$2.2 - $4.54 $2,472 - $5,102
-1,124 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$2.47 - $3.51 $2,776 - $3,945
1,124 New
1,124 $3,000
Q2 2019

Aug 14, 2019

SELL
$3.06 - $51.61 $1,373 - $23,172
-449 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$31.16 - $48.62 $13,990 - $21,830
449 New
449 $17,000
Q4 2018

Feb 14, 2019

SELL
$23.33 - $36.37 $56,971 - $88,815
-2,442 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$29.34 - $35.0 $77,428 - $92,365
-2,639 Reduced 51.94%
2,442 $84,000
Q2 2018

Aug 14, 2018

BUY
$27.33 - $41.46 $136,704 - $207,382
5,002 Added 6331.65%
5,081 $164,000
Q1 2018

May 15, 2018

SELL
$20.21 - $32.0 $20,088 - $31,808
-994 Reduced 92.64%
79 $2,000
Q4 2017

Feb 14, 2018

BUY
$14.55 - $23.99 $15,612 - $25,741
1,073
1,073 $22,000

Others Institutions Holding IFRX

About InflaRx N.V.


  • Ticker IFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,203,800
  • Market Cap $99M
  • Description
  • InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...
More about IFRX
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.